ORIC - Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors | Benzinga
FREMONT, Calif., July 09, 2024 (GLOBE NEWSWIRE) -- Attovia Therapeutics today announced the election of Mitchell H. Gold, M.D., and Angie You, Ph.D., as independent members of its Board of Directors. Drs. Gold and You are seasoned biotech executives and experienced board members who bring decades of industry leadership experience, including early- and late-stage therapeutic development and commercialization.
"I am delighted to welcome Mitch and Angie to the team. They are industry leaders with a proven track record of success in building both public and private biopharma companies. As Attovia looks toward our next stage of growth and drives our mission of bringing forward first-in-class and best-in-class therapies against immune-mediated disease, their expertise will be invaluable in supporting the business and strategic priorities of the company," said Tao Fu, Chief Executive Officer of Attovia Therapeutics.
Dr. Gold was chairman, CEO, and founder of Alpine Immune Sciences, a publicly traded biotech company (NASDAQ:ALPN) dedicated to developing innovative treatments for autoimmune and inflammatory diseases, that was acquired by Vertex Pharmaceuticals in May of 2024 for $4.9 billion. Previously, he was a board member and former president and CEO of Dendreon Corporation, which under his leadership brought the therapeutic cancer vaccine Provenge® through late-stage development and ...